GLPwatch
A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus.
Clin Endocrinol (Oxf) · 2012
Last updated 2026-05-28| Journal | Clin Endocrinol (Oxf), 2012 |
|---|---|
| Citations | 26 |
| Relative citation ratio | 0.81 |
| NIH percentile | 43 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity |
Full record and abstract on PubMed 22356092 ↗